Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to empower black women against HIV

NCT ID NCT06307028

Knowledge-focused Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested a small-group discussion program called SISTA-P for Black women at high risk for HIV. The program covered self-care, HIV and PrEP education, and assertiveness skills. Researchers enrolled 23 women in Washington D.C., Atlanta, and New Orleans to see if the program was feasible and acceptable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
SISTA-P Intervention (behavioral group discussion)
What this could lead to
If successful, this program could help Black women feel more informed and empowered to use HIV prevention tools like PrEP.
What could go wrong
This was a very small, early feasibility study with only 23 participants. It measured intentions, not actual HIV prevention, so real-world impact is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

23 people

The number who actually took part.

Started

Jan 2024

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Black women are eligible if you: * Have sex with men * Are age 18+ * Live in Washington D.C., Atlanta, GA, or New Orleans, LA * Are not HIV+ Exclusion Criteria: * HIV+

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Health behavior, risky are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior Health Behavior Health Risk Behaviors HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Health behavior, risky Health knowledge, attitudes, practice Health-related behavior

Contacts and locations

Locations

  • Rutgers University

    New Brunswick, New Jersey, 08854, United States

  • The Women's Collective

    Washington D.C., District of Columbia, 20002, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.